Nucleoside supplements as treatments for mitochondrial DNA depletion syndrome
Introduction: In mitochondrial DNA (mtDNA) depletion syndrome (MDS), patients cannot maintain sufficient mtDNA for their energy needs. MDS presentations range from infantile encephalopathy with hepatopathy (Alpers syndrome) to adult chronic progressive external ophthalmoplegia. Most are caused by nu...
Main Authors: | Eszter Dombi, Tony Marinaki, Paolo Spingardi, Val Millar, Nastasia Hadjichristou, Janet Carver, Iain G. Johnston, Carl Fratter, Joanna Poulton |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-04-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2024.1260496/full |
Similar Items
-
A new pathogenic POLG variant
by: S. Nicholas Russo, et al.
Published: (2022-09-01) -
Alpers–Huttenlocher syndrome: the role of a multidisciplinary health care team
by: Saneto RP
Published: (2016-07-01) -
Reversible Valproate Hepatotoxicity and Associated Mitochondrial Disease
by: J Gordon Millichap
Published: (2008-02-01) -
Nucleoside supplements as treatments for mitochondrial DNA depletion syndrome
by: Dombi, E, et al.
Published: (2024) -
A novel homozygous variant in MICOS13/QIL1 causes hepato‐encephalopathy with mitochondrial DNA depletion syndrome
by: Yoshihito Kishita, et al.
Published: (2020-10-01)